Glenmark Pharmaceuticals Limited [Glenmark] is an India-based growing pharmaceutical company headquartered at Mumbai [formerly, Bombay]. Incorporated in 1977, the Company is focused on the manufacture and marketing of formulation products and active pharmaceutical ingredients [API] in India as well as globally and enjoys a diversified and growing presence in regulated and developing international markets. Over the past five years, the Company has also catalysed its growth through investment in dedicated research and development including cutting-edge New Chemical Entity [NCE] research.
Company Name | Glenmark |
Post Name | Executive Finance & Accounts |
Location | Mumbai |
Qualification | CMA |
Experience | 02 to 05 Years |
CRISILs majority Stakeholder is Standard & Poors, a division of The McGraw-Hill Companies and the world’s foremost provider of independent credit ratings, indices, risk evaluation, investment research and data. CRISILs globally acclaimed analytical models & process have high-end technology at the heart & are delivered by top-notch technology professionals..Eligibility Criteria / Educational Qualification, Official Notification, Apply Online Form Link & Other Relevant Details for CRISIL limited Recruitment 2021 are provided below.
Company Name | Crisil |
Post Name | Senior Research Analyst – Commodity domain |
Location | Mumbai (All Areas) (WFH during Covid) |
Qualification | CA/MBA/PGDM/CFA |
Experience | 03 to 07+ Years |
Job Description:-
Product Costing
Std BOM & Recipe review with actuals
Std vs Actual variance analysis
Preparation of Stock data for Bank & Insurance
Support in Audit & MIS activities
Accounting of Provisions & expense booking
Knowledge of SAP & MS office is mandatory
Link For Official Notification:- Click Here
Join us on LinkedIn and Telegram Group for regular updates.
Disclaimer: The information provided above is for informational purpose only. This website do not provide any recruitment guarantee. Neither the author nor cmajob and its affiliates accept any liabilities for any loss or damage of any kind arising out of any information in this article nor for any actions taken in reliance thereon.